First patient treated with CSI’s new peripheral support catheter

Cardiovascular Systems, Inc. (CSI), a Minnesota-based healthcare technology company focused on treating peripheral artery disease (PAD) and coronary artery disease (CAD), announced that the first patient has been treated with its ViperCross peripheral support catheter.

Billy J. Kim, MD, a vascular surgeon at the Surgical Clinic in Nashville, completed the procedure.

“With the commercial launch of ViperCross, CSI now offers a complete portfolio of products for the treatment of PAD, including atherectomy, balloon catheters, guidewires, support catheters and embolic protection,” Scott R. Ward, chairman, president and CEO of CSI, said in a statement. “Combined, these products advance our ability to help physicians improve outcomes for patients undergoing complex peripheral interventions.”

“ViperCross offers the right balance of support and flexibility to successfully navigate tortuous anatomy and cross challenging lesions,” Kim added. “In addition, ViperCross provides excellent guidewire support and facilitates easy guidewire exchange.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.